| Serial Number | 90072048 |
| Word Mark | ARGONAUT THERAPUTICS |
| Filing Date | Friday, July 24, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, December 28, 2021 |
| Registration Number | 6600088 |
| Registration Date | Tuesday, December 28, 2021 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, October 12, 2021 |
| Disclaimer with Predetermined Text | "THERAPEUTICS" |
| Description of Mark | The mark consists of large lowercase stylized letters spelling "argonaut" above the word "THERAPEUTICS" in capital letters and a smaller font, above and to the right of the "t" in "argonaut" is a series of concentric circles of various sizes inside a larger circle. |
| Goods and Services | Epigenetic drugs for the treatment, diagnosis, detection and prevention of cancer; epigenetic drugs targeting arginine methylation in cancer; pharmaceutical preparations in the nature of inhibitors of arginine methylation for the treatment of cancer; pharmaceutical preparations in the nature of inhibitors of protein arginine methyl-transferase (PRMT) for the treatment of cancer; cancer treatment vaccines; therapeutic vaccines for treating cancer; cancer therapy subsection vaccines; pharmaceutical compounds for the treatment, diagnosis, detection and prevention of cancer; pharmaceutical products, preparations and substances for the treatment, diagnosis, detection and prevention of cancer; biological preparations and substances for the treatment, diagnosis, detection and prevention of cancer |
| Goods and Services | Research and development services in the pharmaceutical and biotechnology fields; medical research and development services in the pharmaceutical and biotechnology fields; scientific research and development services; pharmaceutical research and development services; research and development in the field of epigenetic drugs for the treatment, diagnosis, detection and prevention of cancer; research and development in the field of epigenetic drugs targeting arginine methylation in cancer; research and development in the field of inhibitors of arginine methylation for the treatment of cancer; research and development in the field of inhibitors of protein arginine methyl-transferase (PRMT) for the treatment of cancer; research and development in the field of cancer treatment vaccines, therapeutic vaccines for treating cancer and cancer therapy subsection vaccines; research and development in the field of compounds for the treatment, diagnosis, detection and prevention of cancer; research and development in the field of pharmaceutical products, preparations and substances for the treatment, diagnosis, detection and prevention of cancer; research and development in the field of biological preparations and substances for the treatment, diagnosis, detection and prevention of cancer; consultancy, advisory and information services relating to and connected with the aforementioned services |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, August 24, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, August 24, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Argonaut Therapeutics Limited |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Oxford OX44GA GB |
| Party Name | Argonaut Therapeutics Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Oxford OX44GA GB |
| Party Name | Argonaut Therapeutics Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Oxford OX44GA GB |
| Event Date | Event Description |
| Tuesday, December 28, 2021 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, October 12, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 12, 2021 | PUBLISHED FOR OPPOSITION |
| Wednesday, September 22, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, September 3, 2021 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Friday, September 3, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, September 3, 2021 | EXAMINER'S AMENDMENT ENTERED |
| Friday, September 3, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, September 3, 2021 | EXAMINERS AMENDMENT E-MAILED |
| Friday, September 3, 2021 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, August 12, 2021 | ASSIGNED TO EXAMINER |
| Wednesday, July 7, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, July 7, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, July 7, 2021 | ASSIGNED TO LIE |
| Monday, May 17, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, November 17, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, November 17, 2020 | NON-FINAL ACTION E-MAILED |
| Tuesday, November 17, 2020 | NON-FINAL ACTION WRITTEN |
| Tuesday, November 10, 2020 | ASSIGNED TO EXAMINER |
| Tuesday, August 25, 2020 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Monday, August 24, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Tuesday, July 28, 2020 | NEW APPLICATION ENTERED IN TRAM |